Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain (original) (raw)

Nature Protocols volume 1, pages 1591–1595 (2006)Cite this article

Abstract

In the current protocol, we describe the Congo red staining method and a method for separately quantifying vascular and parenchymal amyloid deposits in brain tissue sections. Congo red staining detects amyloid deposits in brain tissue of amyloid precursor protein transgenic mice and human Alzheimer's tissue. It detects compacted amyloid in a β-sheet secondary structure and labels amyloid in both the brain parenchyma (amyloid plaques) and blood vessels. Congophilic amyloid in blood vessels is called cerebral amyloid angiopathy (CAA). To date, analysis of CAA has largely used a severity rating scale, including both qualitative and quantitative characteristics. Here, we describe a simple method for quantifying total Congophilic staining and resolution of this staining into the parenchymal and vascular components based on morphological criteria. It is becoming increasingly important to separately quantify various components of the Alzheimer's pathology, given the advancement of amyloid-lowering therapies into clinical trials. The entire procedure for the Congo red staining can be performed at room temperature (20–25 °C) in a fume hood. The staining protocol should take 1 h 30 min including time for coverslipping slides. Time required for image analysis depends greatly on the number of samples being analyzed and the software being used. In our hands, 30 images can be collected per hour and quantified in a further 2 h.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Puchtler, H., Sweat, F. & Levine, M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10, 355–364 1962.
    Article CAS Google Scholar
  2. Rensink, A.A., de Waal, R.M., Kremer, B. & Verbeek, M.M. Pathogenesis of cerebral amyloid angiopathy. Brain Res. Rev. 43, 207–223 (2003).
    Article CAS Google Scholar
  3. Grabowski, T.J., Cho, H.S., Vonsattel, J.P., Rebeck, G.W. & Greenberg, S.M. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49, 697–705 (2001).
    Article CAS Google Scholar
  4. Jellinger, K.A. & Attems, M. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer's disease. J. Neurol. Sci. 229–230, 37–41 (2005).
    Article Google Scholar
  5. Wilcock, D.M. et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J. Neuroinflamm. 1, 24 (2004).
    Article Google Scholar
  6. Chauhan, N.B., Siegel, G.J. & Lichtor, T. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Aβ antibody into the third ventricle of TgCRND8 mice. J. Neurosci. Res. 78, 732–741 (2004).
    Article CAS Google Scholar
  7. Holcomb, L. et al. Accelerated Alzheimer's-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97–100 (1998).
    Article CAS Google Scholar
  8. Gordon, M.N. et al. Time course of the development of Alzheimer's-like pathology in the doubly transgenic PS1+APP mouse. Exp. Neurol. 173, 183–195 (2002).
    Article CAS Google Scholar
  9. Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
    Article CAS Google Scholar

Download references

Acknowledgements

We have been supported by NIH awards AG15490, AG18478, AG25509, AG25711 and NS48335. D.M.W. was a Benjamin Scholar in Alzheimer's Research.

Author information

Authors and Affiliations

  1. Department of Molecular Pharmacology and Physiology, Alzheimer's Research Laboratory, School of Basic Biomedical Sciences, College of Medicine, University of South Florida, Tampa, 33612, Florida, USA
    Donna M Wilcock, Marcia N Gordon & Dave Morgan

Authors

  1. Donna M Wilcock
    You can also search for this author inPubMed Google Scholar
  2. Marcia N Gordon
    You can also search for this author inPubMed Google Scholar
  3. Dave Morgan
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toDave Morgan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Wilcock, D., Gordon, M. & Morgan, D. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain.Nat Protoc 1, 1591–1595 (2006). https://doi.org/10.1038/nprot.2006.277

Download citation

This article is cited by